CLDX FY 2014 Earnings — Celldex Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

CLDXCelldex Therapeutics, Inc.

$2B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M-12.8% YoY

Gross Profit

$185,0005.2% margin

Operating Income

-$122M-3414.1% margin

Net Income

-$118M-3292.8% margin

EPS (Diluted)

$-19.81

Cash Flow

Operating Cash Flow

-$102M

Free Cash Flow

-$103M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$248M

Total Liabilities

$36M

Stockholders' Equity

$212M

Cash & Equivalents

$28M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$4M	-12.8%
Gross Profit	$185,000	$2M	-89.6%
Operating Income	-$122M	-$81M	-50.3%
Net Income	-$118M	-$82M	-44.8%